We tested the effect of four compounds, used in ovary-cancer therapy in the expression of the genes HMGB1, HMGB2, MIEN1 and NOP53 in cultured cancerous SKOV-3 cells and in non-cancerous IOSE-80 ovarian cells. The gene discussed is NOP53; the disease is ovarian cancer.